Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#AntiviralTherapy

Home » #AntiviralTherapy
Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

Dr. Jie Li: Exploring and Prospects of Functional Cure for Chronic Hepatitis B

Posted by By El Bachir MOURABIT 2024.09.08
Editor's Note: Achieving a functional cure for chronic hepatitis B (CHB) has become the recognized ideal treatment goal in both domestic and international guidelines, as it significantly reduces the risk…
Read More
Youth Forum of APACC 2023  | (5R)-5-hydroxytriptolide Holds Promise for HIV immunological Non-responders Receiving ART

Youth Forum of APACC 2023  | (5R)-5-hydroxytriptolide Holds Promise for HIV immunological Non-responders Receiving ART

Posted by By Mourabit Halima 2024.02.14
Hello everyone, I'm Xiaosheng Liu , a graduate student from Professor Taisheng Li's team of Peking Union Medical College Hospital, China. My primary research focus is on the mechanisms underlying…
Read More
APASL 2023 | Prof. Hou Jinlin: The New Hepatitis B Drug ALG-000184 Combined with Entecavir Shows Stronger Antiviral Activity Than Entecavir Alone

APASL 2023 | Prof. Hou Jinlin: The New Hepatitis B Drug ALG-000184 Combined with Entecavir Shows Stronger Antiviral Activity Than Entecavir Alone

Posted by By Mourabit Halima 2024.01.03
Editor's Note: Chronic hepatitis B virus (HBV) infection is a global epidemic, yet we still lack a treatment that can completely conquer HBV. At present, most patients still need long-term…
Read More
Recent Posts
  • FACO China–Japan Expert Dialogue | Professors Jin Li, Xiaotian Zhang, and Koji Kono Discuss Precision Treatment Advances in HER2-Positive Gastric Cancer
  • Highlights from the 13th International Conference of the Federation of Asian Clinical Oncology (FACO 2025)
  • 2025 FACO | Professors Tetsuya Mitsudomi & Yun Gyoo Lee: Strengthening China–Japan–Korea Collaboration to Address Shared Challenges in Lung Cancer Care
  • Professors Michael R. Bishop and Edmund K. Waller Visit Peking University Institute of Hematology:Sino–U.S. Experts Discuss the Future of Cell Therapy
  • Prof. Kun Wang: A 72-Hour Pegfilgrastim Dosing Strategy Significantly Reduces Bone Pain and Optimizes Supportive Care in Breast Cancer
Recent Comments
    Archives
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Media Medic Publishing Company Limited(HK)
    赛美出版有限公司(香港)
    Scroll to Top